Clinical Trial Update: Efficacy/Safety of Imprime PGG With Cetuximab & Paclitaxel/Carboplatin Therapy in Pts With Untreated Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated Imprime PGG in combination with cetuximab and paclitaxel/carboplatin for untreated advanced non-small cell lung cancer; results were pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Cetuximab (cetuximab)
• Imprime PGG
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: HiberCell, Inc. | Conditions: NSCLC | Phase 2 | Status: COMPLETED | Results posted: 2016-11-29